In today’s rapidly evolving scientific landscape, eliminating barriers to progress is more critical than ever. Precision medicine and targeted therapies hold great promise but are dependent on the ...

Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...

Strategic partnership marks launch of early access program offering rapid, long, clonal gene synthesis and high-complexity genes up to 15 kb The partnership strengthens IDT’s robust synthetic biology ...

SAN CARLOS, Calif.--(BUSINESS WIRE)--Elegen, the leader in next-generation DNA manufacturing, today announced the launch of ENFINIA™ Plasmid DNA, a faster, cost-effective solution for clonal synthesis ...

High-fidelity oligo synthesis was key for experimentally confirming AI-predicted DNA sequences linked to favorable gene expression changes controlling desired crop traits. Feeding a growing global ...